14 biotech podcasts to tune into in 2026 

Podcasts are a great way to learn and engage listeners with stories that may strike their interest, particularly in the world of biotech. Whether you’re commuting to work, cleaning the house, going for a walk, doing the laundry, or just sitting down to relax, podcasts can be an ideal way to stay entertained – as well as informed – while multitasking.  

As keeping up with the latest technologies in the biotech and pharmaceutical industries can be quite daunting, especially at a time of rapid advancements, a podcast can be an enjoyable way to stay up to date with the latest trends in the industry.  

Here are 14 biotech podcasts that have been gaining traction, thanks to their compelling stories, diverse topics, and innovative formats this year. 

Beyond Biotech  

Top of the list, of course, is Labiotech’s very own Beyond Biotech podcast hosted by Director of Editorial, Dylan Kissane. Every Friday, a new episode features global biopharma industry experts, including investors, chief executives, and researchers. They share insights on clinical trials, emerging trends, and the latest therapies and technologies. This year kicked off with an interview with M Ventures’ Hakan Goker, who discussed rising mergers and acquisitions (M&As) in biopharma dealmaking of late. Keep an ear out for this week’s episode on the rundown of Labiotech’s picks of 15 biotech companies of 2026. 

Biotech Career Coach 

Are you looking to advance your career in biotech but don’t know where to begin? The Biotech Career Coach podcast hosted by Carina Clingman, the founder of The Collaboratory Career Hub, offers advice for job-seekers looking to make it in the biotech and life sciences industry. Episodes cover a wide range of topics, from career trends, the dos-and-don’ts when writing your resume, to building your biotech network. This year, the podcast opened with an episode on career goals for 2026 and the perks of applying for roles this January. 

Biotech2050 

The life science industry is moving at a pace like never before. The Biotech2050 podcast, led by Alok Tayi, chief executive officer (CEO) of Massachusetts-based biotech Vibe Bio, and Rahul Chaturvedi, CEO of life science partnering platform Clora, takes a deep dive into technologies that are on the path to shaping the industry. On an episode that was produced late last year, Chaturvedi was joined by American multinational healthcare company Roivant Sciences’ CEO Matt Gline, who discussed what it really takes to build a biotech company that lasts and outlined the company’s candidate to treat the autoimmune condition dermatomyositis, a challenging therapeutic space for drug developers.  

Business of Biotech 

Hosted by Ben Comer, the chief editor of Life Science Leader magazine, the Business of Biotech podcast is joined by industry experts who delve into drug development, funding, and commercialization of the latest technologies. The episodes feature these experts, who share their experiences growing their companies, developing drugs in emerging biotech spaces, as well as offer their pearls of wisdom to budding entrepreneurs and investors. The latest episode featured Zymeworks’ CEO Kenneth Galbraith, who discussed the Canadian company’s shift to a royalty model for value creation. 

The Long Run 

The show’s title, an ode to Ernest Shackleston’s Antarctic explorations, The Long Run is a podcast run by biotech journalist Luke Timmerman, where he goes beyond the realms of R&D in biotech, and has had conversations with spokespeople about race and gender inequality within the biotech sector. Timmerman has interviewed industry experts about how supporting young scientists could be critical to boosting research and development, among other subjects catered to aspiring scientists. The latest episode had Kate Haviland, former CEO of Blueprint Medicines, who talked about Blueprint went from being an immunology company to its $9.5 billion acquisition by pharma giant Sanofi last year. 

The Readout Loud 

Ever wonder how your medicines get made? Reporters Adam Feuerstein, Elaine Chen, and Allison DeAngelis at Stat News host The Readout Loud podcast, which explores the latest drug discoveries, trials, and trends. Previously, they have discussed the boom in the radiopharmaceutical development sector and the gold rush that followed. The podcast has also covered major mergers and acquisitions within the industry and has kept up with the latest gene editing techniques and medicines like weight loss drug Ozempic that caused a market frenzy last year. With the ongoing JPM buzz, the latest episode predicts what will happen at the event and potential deals that will be closed this year. 

The Bio Report 

Hosted by award-winning journalist Daniel Levine, The Bio Report is a weekly podcast that gives insight into topics that intersect with business, science, and policy. Past episodes have dealt with supply-chain challenges that underlie drug shortages in the field of synthetic biology and how to develop better and more affordable vaccines, particularly in a post-pandemic era. Recurring topics on the podcast include artificial intelligence in healthcare, diagnostics, and drug discovery as well as drug development across various therapeutic fields. Most recently, the podcast delved into the challenges in treating Alzheimer’s disease and how AltPep’s new synthetic peptides could help treat the neurodegenerative condition. 

Inside Biotech 

The Inside Biotech podcast covers all things biotech. Currently hosted by the Biotech Connection Los Angeles (BCLA)’s Gabriella Rubert, the podcast explores emerging technologies and innovations behind startups mainly based in California, a prime biopharma hub. In its most recent episode, Rubert was in conversation with fellow BCLA members, reflecting on the world of science communication, storytelling and how it plays a role in connecting the scientific community and the public. 

Tiny Expeditions 

Getting into the nitty gritty of genetics and DNA, Tiny Expeditions journeys through the lab and connects with scientists from various fields. Season one dealt with animal morphology and the role of genetics, season two digs into agricultural science and biotech, season three zones into the impact of genomics in the manifestation of disease and their role in therapeutics, and season four gets into how genetic technology could be applied to solving global problems that threaten the world today. Season five, which explored the influence of biotech and science on cinema, ended in 2025, with the finale taking listeners through screenwriting science fiction and the portrayals of technology in film. The theme for season six was brain health and it concluded with an episode on brain wellness and Alzheimer’s prevention late last year. 

Talking Biotech 

Talking Biotech features interviews with scientists across a wide range of fields within biotechnology, from plant biology to human medicine, as well as experts on science communication. It is led by professor and horticulture researcher Kevin Folta and digs into research that connects biology and engineering. Each episode explores how science and technology can transform agriculture, protect the environment, and feed billions of people by 2050. A recent episode had on a doctor who discussed the critical role of dietary fiber, probiotics, and how to overcome deficiencies. 

Biotech Hangout 

The Biotech Hangout podcast, began at the start of the COVID-19 pandemic as a means to stay connected to the latest biotech-related news and trends, and it amassed a following soon enough. Founders and industry insiders Daphne Zohar, Brad Loncar, and Chris Garabedian, are joined by their co-hosts every Friday to provide a rundown of breaking news in the industry, data deals and U.S. Food and Drug Administration (FDA) actions, as well as focus on funding trends and the environment at large. The latest episode reviewed the current biotech market sentiment as JPM is on full swing this week. 

The Science Marketer  

Hosted by Labiotech’s former managing director and Biocom’s CEO Joachim Eeckhout, The Science Marketer podcast captures the world of science marketing and communication. The biweekly podcast follows the minds of founders and industry leaders in the life sciences sector, who offer advice and discuss the lessons learned from challenges that come with the job. The latest episode tapped into how to build a scientific community in a fast-growing ecosystem. 

The Life Science Rundown 

Hosted by The FDA Group, The Life Science Rundown is a podcast for people in the life science space looking to learn about FDA regulations, drug approvals, and marketing in the U.S. The latest episode featured the chief quality officer of Colorado-based pharmaceutical Tolmar and microbiologist Chris Masterson, who got down to the brass tacks of quality-centric culture and how to sustain it. 

Becker’s Healthcare 

Featuring interviews on healthcare’s pressing problems, the team at the Becker’s Healthcare podcast follows medical matters that concern the U.S. public. The most recent episode discussed the rising demand for cancer care, improving diagnoses, and addressing patient needs in the U.S. 

As we dive into 2026, there is a lot to look forward to this year. Tuning into these podcasts could be a great way to get your weekly dose of biotech news and keep up with the ever-changing industry.